Pfizer UK removes sales incentives for anti-infectives
28 September 2019
Pfizer UK has changed how it incentivises its anti-infectives field-force under the drug giant’s commitment to the fight against antimicrobial resistance (AMR).
All sales have been ‘de-linked’ from its anti-infectives (AI) field-force incentives, with the focus now on measuring management-based objectives (MBOs) centering on generating access to medicines and promoting the appropriate use of antibiotics.
Further reading: PharmaTimes
Author(s): Pharmatimes
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!
